Brief: Suven Life Sciences Gets Product Patents In India, Singapore,South Korea And Israel
July 4 (Reuters) - Suven Life Sciences Ltd SUVP.NS :
* SECURES PRODUCT PATENTS IN INDIA, SINGAPORE,SOUTH KOREA
AND
ISRAEL
* SAYS PATENTS ARE VALID THROUGH 2031, 2034, 2034 AND 2036
* SUVEN LIFE SCIENCES - GRANT OF PATENTS CORRESPONDING TO
NEW
CHEMICAL ENTITIES FOR TREATMENT OF DISORDERS ASSOCIATED WITH
NEURODEGENERATIVE DISEASES
Source text - http://bit.ly/2KLSZzd
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences Says First Patient Randomized In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences March-Quarter Consol Net Loss 439.4 Million Rupees